Small Things Getting Big Importance

Size is becoming one of the key success factors today across many industries in this shrinking world. From cars to iPods, we see size and opportunity becoming more inversely proportional. Healthcare sector is no different in this trend. When it comes to instruments used in research/ diagnostics laboratories or even in point-of-care setting, reducing the foot print is given a top priority. Advancements in the development of micro total analysis systems (uTAS or mTAS) or lab-on-chip has slowly gained importance in various fields of which lifesciences is one of the major application areas.

Has the Global Financial Meltdown Reached its Boiling Point? European High Acuity Monitoring Segment Outlook

The healthcare industry in general and the high acuity patient monitoring segment in particular has not been that vulnerable to the precarious economic environment prevailing over Europe.

Surviving a Bottleneck - Insights into Managing Exponential Growth of Digitized Medical Images

Medical image data are becoming an increasingly important aspect for effective patient diagnosis.  There is an increasing trend of medical images being viewed and stored in digital format as opposed to the traditional film based images.

PC/Mobile Computing in Lab Environments

As information technologies reshape the healthcare sector as a whole, hospitals have become more comfortable with accessing and sharing electronic information. Real-time access to information is very critical for an effective healthcare. It has been proven time and again that the most efficient means of information entry and access is offered by a combination of computing devices. It is acknowledged that wireless networks, which will aid point-of-care decision-making, information access and clinical data entry, are coming up steadily.

Pharmacogenomics and Personalized Medicine: Just a Technology Bubble or an Opportunity for Investment?

The pharmaceutical industry is facing some key challenges such as the increase in drug development cost, the decrease in the number of drugs being approved, and scrutiny from regulatory authorities to name a few.  Patients themselves are demanding more effective and safer drugs.

The European Biosimilars Market: Trends and Key Success Factors

The European biopharmaceuticals market currently accounts for approximately 45% of the global market, and is expected to grow at over 10% during the forecast period. According to figures by the European generic association (EGA), generic medicines have made a major contribution to affordable and accessible healthcare for over 20 years, saving the European Union (EU) alone an estimated €20 billion annually.

Lead Discovery: Laying Foundations for Next-generation Drug Design

Nanotechnology: Roadmap to Early Diagnosis of Disease

Nanotechnology has attracted over $3 billion in funds from governments globally, which is being applied to a broad range of disciplines including pharmaceuticals, drug delivery, aerospace/defense and food

Current Trends in Genomic Applications within Europe

Healthcare and Emerging Rich Web Technologies – The WEB 2.0/Semantic Web Challenge and Opportunity